California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

Lawmakers have focused on the high cost of diabetes drugs. The announcement will make state-branded insulin available two years later than the governor originally promised.

Gov. Gavin Newsom announced Thursday he is rolling out an effort to lower the price of insulin to $11. CalRx, the state-run program that aims to lower the cost of insulin and other medications, would ...

In an expansion of its previous moves to cut insulin prices, Sanofi will cap the price of each of its insulin products at $35 per month in the U.S. regardless of a patient's insurance status. The move ...

Limited time only. Minimum spend of $350. Selected products only. For full terms and conditions please visit the website. This offer is valid on Ozempic, Mounjaro KwikPen, Wegovy, Rybelsus, and ...

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the US—Caremark, Express Scripts, and Optum Rx—of inflating insulin costs for ...

Nearly three years after it was signed into law, President Biden’s American Rescue Plan is still paying dividends, this time by prompting the nation’s three major insulin makers to drop their prices ...

Sanofi formed a landmark partnership with insulin manufacturers Novo Nordisk and Eli Lilly to help millions of Americans with diabetes afford medication, unveiling a comprehensive strategy involving ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

More Americans with diabetes will get a break on their insulin costs in 2024. Sanofi is joining the nation's two other major insulin manufacturers in offering either price caps or savings programs ...